Epithelial Mesothelioma Withdrawn Phase 2 Trials for Pemetrexed (DB00642)

IndicationStatusPhase
DBCOND0029617 (Epithelial Mesothelioma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01105390AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaTreatment